scPharmaceuticals Inc. (NASDAQ: SCPH)
$5.09
+0.3600 ( +7.61% ) 400.5K
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.
Market Data
Open
$5.09
Previous close
$4.73
Volume
400.5K
Market cap
$183.16M
Day range
$4.71 - $5.12
52 week range
$3.24 - $8.78
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jan 03, 2024 |
4 | Insider transactions | 1 | Jan 03, 2024 |
8-k | 8K-related | 13 | Nov 08, 2023 |
10-q | Quarterly Reports | 72 | Nov 08, 2023 |
8-k | 8K-related | 14 | Sep 20, 2023 |
8-k | 8K-related | 13 | Aug 10, 2023 |
10-q | Quarterly Reports | 72 | Aug 10, 2023 |